Browsing Conference/ Workshop/ Seminar/ Proceedings by Author "Celum, C"
Now showing items 1-2 of 2
-
Fertility intentions and interest in early antiretroviral therapy among East African HIV-1-infected individuals in serodiscordant partnerships.
Mujugira, A; Heffron, R; Celum, C; Mugo, N; Nakku-Joloba, E; Baeten, JM; Bukusi, EA (Epidemiology, University of Nairobi, 2013) -
High-dose valacyclovir HSV-2 suppression results in greater reduction in plasma HIV-1 levels compared with standard dose acyclovir among HIV-1/HSV-2 coinfected persons: a randomized, crossover trial.
Mugwanya, K; Baeten, JM; Mugo, NR; Irungu, E; Ngure, K; Celum, C (Infectious Diseases Institute, Makerere University, Kampala, Uganda, 2011)Standard-dose HSV-2 suppressive therapy (acyclovir 400 mg twice daily) reduces plasma HIV-1 levels by 0.25-0.50 log(10) copies/mL. It is not known if higher doses might further suppress HIV-1 levels. METHODS: We enrolled ...